ArticleGastroenterology2025

Rifaximin Does Not Increase the Rate of 30-Day Mortality in Patients With Cirrhosis and Daptomycin in Two National US-Based Cohorts.

Scott Silvey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.